ERSOY, B. Et Al. 2018. Asymmetric dimethylarginine levels and diabetes duration: Relationship with measures of subclinical atherosclerosis and cardiac function in children and adolescents with Type 1 diabetes. Diabetes and Vascular Disease Research , vol.15, no.3 , 196-203.

ERSOY, B., Eroğlu, N., Çetin, M., ONUR, E., ÖZKOL, M., & COŞKUN, Ş., (2018). Asymmetric dimethylarginine levels and diabetes duration: Relationship with measures of subclinical atherosclerosis and cardiac function in children and adolescents with Type 1 diabetes. Diabetes and Vascular Disease Research , vol.15, no.3, 196-203.

ERSOY, BETÜL Et Al. "Asymmetric dimethylarginine levels and diabetes duration: Relationship with measures of subclinical atherosclerosis and cardiac function in children and adolescents with Type 1 diabetes," Diabetes and Vascular Disease Research , vol.15, no.3, 196-203, 2018

ERSOY, BETÜL Et Al. "Asymmetric dimethylarginine levels and diabetes duration: Relationship with measures of subclinical atherosclerosis and cardiac function in children and adolescents with Type 1 diabetes." Diabetes and Vascular Disease Research , vol.15, no.3, pp.196-203, 2018

ERSOY, B. Et Al. (2018) . "Asymmetric dimethylarginine levels and diabetes duration: Relationship with measures of subclinical atherosclerosis and cardiac function in children and adolescents with Type 1 diabetes." Diabetes and Vascular Disease Research , vol.15, no.3, pp.196-203.

@article{article, author={BETÜL ERSOY Et Al. }, title={Asymmetric dimethylarginine levels and diabetes duration: Relationship with measures of subclinical atherosclerosis and cardiac function in children and adolescents with Type 1 diabetes}, journal={Diabetes and Vascular Disease Research}, year=2018, pages={196-203} }